Knowledge Center

Article / May 08, 2026

Overcoming Dose Limitations in Pulmonary Delivery

Authors:
  • Rui Churro
Source:
Hovione Expert Insights

Drug administration via the lungs dates back to antiquity, evolving from ancient rituals and herbal remedies to the rise of modern pharmacology. 

Despite this, drug delivery to the lungs is still one of the most sophisticated frontiers in medicine, leveraging a deeper understanding of the biology of respiratory diseases, airway structures, and aerosol transport and deposition.

Read the full article

 

 

Related links

Read the full article here

Also in the Knowledge Center

Related Content

Dispersome®

Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more

Corticosteroids

Corticosteroids are produced in two dedicated buildings on the Loures site, which are equipped with vessels ranging from 50L up to 4000L.

Page
Read more

ASD-HIPROS

ASD-HIPROS, Hovione’s Intelligent Proprietary Screening, is the most advanced and accurate tool to identify Amorphous Solid Dispersion formulations by Spray Drying with maximum performance and stability.

Page
Read more